Steve Schonfeld’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4M Hold
2,000
0.01% 977
2026
Q1
$1.84M Hold
2,000
0.01% 863
2025
Q4
$2.15M Buy
+2,000
New +$1.91M 0.01% 851
2025
Q2
Sell
-6,600
Closed -$5.45M 2319
2025
Q1
$5.45M Buy
+6,600
New +$5.49M 0.03% 499
2024
Q2
Sell
-700
Closed -$545K 2382
2024
Q1
$545K Buy
+700
New +$498K ﹤0.01% 1452
2023
Q3
Sell
-25,000
Closed -$635K 2059
2023
Q2
$635K Buy
+25,000
New +$10.5M 0.01% 1128

Other funds holding LLY

Steve Schonfeld's LLY Position: Q2 2026 in Review

Steve Schonfeld increased its Eli Lilly (LLY) stake by 816% in Q2 2026, buying an estimated $219M and bringing the position to 240,327 shares worth $48.5M. The position accounts for 0.17% of the portfolio, ranked #96.

Steve Schonfeld first reported a position in LLY in Q4 2016 and has held it in 30 quarters since. The position peaked at $74.1M in Q2 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Steve Schonfeld held 240,327 shares of Eli Lilly worth $48.5M as of Q2 2026.
  • Steve Schonfeld bought 214,090 Eli Lilly shares in Q2 2026, an estimated $219M.
  • Eli Lilly made up 0.17% of Steve Schonfeld's portfolio in Q2 2026, its #96 holding.
  • Steve Schonfeld first reported a position in Eli Lilly in Q4 2016 and has held it in 30 quarters since.
  • Steve Schonfeld's Eli Lilly position peaked at $74.1M in Q2 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.